Tag: Meniere’s Disease
Middle Ear Pressure Therapy Aids Vertigo Symptoms
Symptoms improved with the EFET01 device in both patients with Meniere disease and delayed endolymphatic hydrops
Thicker Choroid, Haller Layer Seen on Ipsilateral Side in Meniere Disease
In addition, significant difference seen in mean subfoveal LCV thickness values, mean subfoveal LCV thickness/mean SCT
Low-Tone Descending Hearing Loss Seen With Endolymphatic Hydrops and Sudden Symptoms
Endolymphatic hydrops is risk factor for subsequent development of Meniere disease
Alterations in Functional Network Reorganization ID’d in Meniere Disease
Degree of functional connectivity lower in MD versus healthy controls in 19 brain areas, including somatomotor, auditory networks
Predictors of Vertigo After Endolymphatic Sac Surgery ID’d in Meniere Disease
Audiogram type and pure-tone threshold average can predict vertigo after endolymphatic sac decompression in Meniere disease
Nonvisualization of the Endolymphatic Duct, Sac Common in Meniere Disease
MD-140 subtype may be tied to worse clinical symptoms
Three Factors Can ID Conservative Treatment Response in Meniere Disease
Decreased vertigo severity, reduced comorbidity burden, absence of hearing loss linked to conservative treatment response
Endolymphatic Hydrops Denotes Degree of Hearing Loss in Meniere Disease
Three-dimensional real inversion recovery sequence can be used to indicate the degree of hearing loss
No Change Seen in Frequency of Recurrent Vertigo Attacks Over Time
Attack frequency did not change over three years for people with benign recurrent vertigo, Meniere disease, or vestibular migraine
Clinical Severity Staging System May Aid Tx Selection for Meniere Disease
Decreased vertigo severity, comorbidity burden, and absence of hearing loss tied to conservative treatment response
